BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]
Larsen S, Butthongkomvog K, Manikhas A, et al. Breast Cancer: Targets and Therapy. 2014;6:179–189.On page 184 there is an error in Figure 3A. The error consists of a yellow bar at +16 days in the placebo group. Read the original article
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/944f9e6b8bb04a3583a2cd6514f4fbcb |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!